Mirati Therapeutics, Inc.

MRTX · NASDAQ
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Assets
Cash & Equivalents$258,718$129,866$241,925$235,260
Short-Term Investments$717,716$649,568$660,369$848,577
Receivables$20,129$15,698$6,227$865
Inventory$20,156$8,644$3,849$3,020
Other Curr. Assets$19,361$15,141$26,980$21,239
Total Curr. Assets$1,036,080$818,917$939,350$1,108,961
Property Plant & Equip (Net)$51,112$52,298$52,968$53,662
Goodwill$0$0$0$0
Intangibles$14,138$14,397$14,655$14,914
Long-Term Investments$3,559$4,565$3,353$3,465
Tax Assets$24,199$24,246$0$0
Other NC Assets$620$620$23,435$21,645
Total NC Assets$93,628$96,126$94,411$93,686
Other Assets$0$0$0$0
Total Assets$1,129,708$915,043$1,033,761$1,202,647
Liabilities
Payables$37,961$32,507$22,320$38,861
Short-Term Debt$8,020$7,961$7,902$7,844
Tax Payable$0$0$0$0
Deferred Revenue-$8,020-$7,961$0$0
Other Curr. Liab.$91,398$99,522$94,378$112,743
Total Curr. Liab.$137,379$139,990$124,600$159,448
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$45,864$46,102$46,531$46,683
Total NC Liab.$45,864$46,102$46,531$46,683
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$183,243$186,092$171,131$206,131
Equity
Pref Stock$0$0$0$0
Common Stock$70$58$58$58
Retained Earnings-$2,976,292-$2,814,388-$2,637,475-$2,452,889
AOCI-$1,550-$1,715-$1,707-$3,719
Other Equity$3,924,237$3,544,996$3,501,754$3,453,066
Total Equity$946,465$728,951$862,630$996,516
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,129,708$915,043$1,033,761$1,202,647
Net Debt-$250,698-$121,905-$234,023-$227,416
Mirati Therapeutics, Inc. (MRTX) Financial Statements & Key Stats | AlphaPilot